Birdwatch Note Rating
2024-01-15 20:17:51 UTC - HELPFUL
Rated by Participant: 77F3621FF8FA173FA4ACD668DF010C276EAE695AC375074FD5F7766FA71A337C
Participant Details
Original Note:
Context: Vivek Ramaswamy owns a 7% stake in Roivant Sciences. Roivants financial interests in lipid nanoparticle delivery systems are publicly available in legal filings. Patent litigation involving Genevant/Roivant and Moderna are pending, they have not yet received profit https://investor.roivant.com/static-files/a7b36392-1f44-4251-87cf-8dd572f3034e https://www.fiercepharma.com/pharma/pandemic-patent-fights-continue-arbutus-genevant-coming-after-pfizer-and-biontech-new-suit
All Note Details